- Home
- NITO vs SLRX Comparison
NITO vs SLRX Comparison
Compare NITO & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NITO
- SLRX
- Stock Information
- Founded
- NITO 2009
- SLRX N/A
- Country
- NITO Israel
- SLRX United States
- Employees
- NITO N/A
- SLRX N/A
- Industry
- NITO
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- NITO
- SLRX Health Care
- Exchange
- NITO NYSE
- SLRX Nasdaq
- Market Cap
- NITO 2.2M
- SLRX 2.1M
- IPO Year
- NITO N/A
- SLRX N/A
- Fundamental
- Price
- NITO $1.37
- SLRX $1.71
- Analyst Decision
- NITO
- SLRX
- Analyst Count
- NITO 0
- SLRX 0
- Target Price
- NITO N/A
- SLRX N/A
- AVG Volume (30 Days)
- NITO 50.6M
- SLRX 101.2K
- Earning Date
- NITO 11-14-2024
- SLRX 11-14-2024
- Dividend Yield
- NITO N/A
- SLRX N/A
- EPS Growth
- NITO N/A
- SLRX N/A
- EPS
- NITO N/A
- SLRX N/A
- Revenue
- NITO $175,308.00
- SLRX N/A
- Revenue This Year
- NITO N/A
- SLRX N/A
- Revenue Next Year
- NITO N/A
- SLRX N/A
- P/E Ratio
- NITO N/A
- SLRX N/A
- Revenue Growth
- NITO N/A
- SLRX N/A
- 52 Week Low
- NITO $0.16
- SLRX $1.22
- 52 Week High
- NITO $3.49
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- NITO 61.81
- SLRX 55.41
- Support Level
- NITO $0.23
- SLRX $1.56
- Resistance Level
- NITO $3.49
- SLRX $1.84
- Average True Range (ATR)
- NITO 0.28
- SLRX 0.18
- MACD
- NITO 0.18
- SLRX 0.03
- Stochastic Oscillator
- NITO 36.32
- SLRX 58.33
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.